Representatives of Ekron in the state of Ohio, will come to the "2010 Biomed Israel Week", with a host of benefits for the Israeli companies: up to one million dollars for the company, research funding, assistance in raising capital from international funds, and the purchase of space and equipment. And already the first to join: the startup company NI Medical
Ekron Ohio from the USA will offer far-reaching benefits to Israeli biomed companies that will expand their activities to the biomedical complex established in the city. In favor of the issue, a multi-participant delegation, which will include senior managers from three hospitals, representatives of the Institute for Innovation Bio, representatives of universities and CEOs of private and government companies. The delegation will be headed by Donald Flosquik, the mayor of Ekron.
The state of Ohio has turned the recruitment of biotechnology and medical companies into a national project. As part of the project that was established five years ago, 729 million dollars were invested and distributed among 69 biomed companies. For the years 2010 and 2011, the state of Ohio committed to an investment of over 200 million dollars to the various bio companies, with companies that meet the criteria being able to receive grants of up to a million dollars each. Among other things, the program includes research scholarships, connecting the companies to venture capital funds, providing training by business and technology experts, easing the tax burden, and assistance in obtaining places for research and equipment for the development of medical innovations.
A huge biomedical complex was established in the city of Ekron, Ohio, which centers biotechnological developments, products and services in the field of biomed. Don Flosquik, Mayor of Ekron, Bob Bowman, Deputy Mayor, and Dr. Ze'ev Gurion, President of New Global Ventures, (a company belonging to the Municipality of Ekron) will attend the "Week Biomed Israel 2010", which will be held between June 14 and 16, In order to present the project and offer Israeli biomed companies to benefit from their support and financial support, they also offer collaborations between the researchers coming from outside of Ohio "The state of Ohio expresses a continuous and frequent interest in the Israeli start-up companies, and the incentives vary according to the size of the company, and the number of local employees planned to be employed by it," says Flusvik.
According to Dr. Gurion, one Israeli startup company has already announced its participation in the project - NI Medical Co., Ltd., which develops equipment for detecting heart disease in large populations, which won a grant of about half a million dollars. The company plans to move the production and marketing systems to Ohio and by the year 2010 will employ 30 employees.
ILSI- Biomed Israel 2010
"ILSI - Biomed Israel 2010" week is the main annual event of the life sciences industry in Israel. This week includes an international professional conference with the participation of the best experts (CEOs and executives of companies in the field of biopharma and medical devices, scientists and researchers, entrepreneurs, researchers, shapers of public opinion in the field, managers of venture capital funds and private investors) from Israel and the world, and an exhibition that presents the hottest innovations "ILSI - Biomed Israel 2010", which received international recognition and is considered the second largest conference in the world - after the USA, It will be held between June 14 and 16 at the David Intercontinental in Tel Aviv.
